BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chen J, Huang XF, Shao R, Chen C, Deng C. Molecular Mechanisms of Antipsychotic Drug-Induced Diabetes. Front Neurosci 2017;11:643. [PMID: 29209160 DOI: 10.3389/fnins.2017.00643] [Cited by in Crossref: 37] [Cited by in F6Publishing: 34] [Article Influence: 7.4] [Reference Citation Analysis]
Number Citing Articles
1 Linnaranta O, Trontti KT, Honkanen J, Hovatta I, Keinänen J, Suvisaari J. Peripheral metabolic state and immune system in first-episode psychosis - A gene expression study with a prospective one-year follow-up. J Psychiatr Res 2021;137:383-92. [PMID: 33765450 DOI: 10.1016/j.jpsychires.2021.03.013] [Reference Citation Analysis]
2 Li DJ, Yue Q, Liu L, Che KK, Liu XM, Hu CH. Brexpiprazole caused glycolipid metabolic disorder by inhibiting GLP1/GLP1R signaling in rats. Acta Pharmacol Sin 2021;42:1267-79. [PMID: 33976388 DOI: 10.1038/s41401-021-00680-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
3 Ishikawa S, Yamamura R, Hashimoto N, Okubo R, Sawagashira R, Ito YM, Sato N, Kusumi I. The type rather than the daily dose or number of antipsychotics affects the incidence of hyperglycemic progression. Prog Neuropsychopharmacol Biol Psychiatry 2022;113:110453. [PMID: 34637872 DOI: 10.1016/j.pnpbp.2021.110453] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Lopez-Herranz M, Jiménez-García R, Ji Z, de Miguel-Diez J, Carabantes-Alarcon D, Maestre-Miquel C, Zamorano-León JJ, López-de-Andrés A. Mental Health among Spanish Adults with Diabetes: Findings from a Population-Based Case-Controlled Study. Int J Environ Res Public Health 2021;18:6088. [PMID: 34200056 DOI: 10.3390/ijerph18116088] [Reference Citation Analysis]
5 Lindekilde N, Nefs G, Henriksen JE, Lasgaard M, Schram M, Rubin K, Rutters F, Kivimaki M, Pouwer F. Psychiatric disorders as risk factors for the development of type 2 diabetes mellitus: an umbrella review protocol. BMJ Open 2019;9:e024981. [PMID: 31152031 DOI: 10.1136/bmjopen-2018-024981] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
6 Mazereel V, Detraux J, Vancampfort D, van Winkel R, De Hert M. Impact of Psychotropic Medication Effects on Obesity and the Metabolic Syndrome in People With Serious Mental Illness. Front Endocrinol (Lausanne) 2020;11:573479. [PMID: 33162935 DOI: 10.3389/fendo.2020.573479] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
7 Han M, Lian J, Su Y, Deng C. Cevimeline co-treatment attenuates olanzapine-induced metabolic disorders via modulating hepatic M3 muscarinic receptor: AMPKα signalling pathway in female rats. J Psychopharmacol 2021;:2698811211050549. [PMID: 34694173 DOI: 10.1177/02698811211050549] [Reference Citation Analysis]
8 Parksepp M, Leppik L, Koch K, Uppin K, Kangro R, Haring L, Vasar E, Zilmer M. Metabolomics approach revealed robust changes in amino acid and biogenic amine signatures in patients with schizophrenia in the early course of the disease. Sci Rep 2020;10:13983. [PMID: 32814830 DOI: 10.1038/s41598-020-71014-w] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
9 Guest PC. Insulin Resistance in Schizophrenia. Adv Exp Med Biol 2019;1134:1-16. [PMID: 30919329 DOI: 10.1007/978-3-030-12668-1_1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
10 Abo Alrob O, Alazzam S, Alzoubi K, Nusair MB, Amawi H, Karasneh R, Rababa'h A, Nammas M. The Effect of Long-Term Second-Generation Antipsychotics Use on the Metabolic Syndrome Parameters in Jordanian Population. Medicina (Kaunas) 2019;55:E320. [PMID: 31261805 DOI: 10.3390/medicina55070320] [Reference Citation Analysis]
11 Vedal TSJ, Steen NE, Birkeland KI, Dieset I, Reponen EJ, Laskemoen JF, Rødevand L, Melle I, Andreassen OA, Molden E, Jönsson EG. Adipokine levels are associated with insulin resistance in antipsychotics users independently of BMI. Psychoneuroendocrinology 2019;103:87-95. [PMID: 30659986 DOI: 10.1016/j.psyneuen.2019.01.001] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
12 Holt RIG. Association Between Antipsychotic Medication Use and Diabetes. Curr Diab Rep 2019;19:96. [PMID: 31478094 DOI: 10.1007/s11892-019-1220-8] [Cited by in Crossref: 22] [Cited by in F6Publishing: 12] [Article Influence: 7.3] [Reference Citation Analysis]
13 Zhao T, Zhang K, Zhang Y, Yang Y, Ning X, Hu Y, Li X, Zhang Y, Xia L, Ren Z, Liu H. Do proinflammatory cytokines play a role in clozapine-associated glycometabolism disorders? Psychopharmacology (Berl) 2021;238:1979-90. [PMID: 33774704 DOI: 10.1007/s00213-021-05824-9] [Reference Citation Analysis]
14 Sabunciyan S. Gene Expression Profiles Associated with Brain Aging are Altered in Schizophrenia. Sci Rep 2019;9:5896. [PMID: 30976116 DOI: 10.1038/s41598-019-42308-5] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
15 Lindekilde N, Rutters F, Erik Henriksen J, Lasgaard M, Schram MT, Rubin KH, Kivimäki M, Nefs G, Pouwer F. Psychiatric disorders as risk factors for type 2 diabetes: An umbrella review of systematic reviews with and without meta-analyses. Diabetes Res Clin Pract 2021;176:108855. [PMID: 33965448 DOI: 10.1016/j.diabres.2021.108855] [Reference Citation Analysis]
16 Ilan Y. Overcoming Compensatory Mechanisms toward Chronic Drug Administration to Ensure Long-Term, Sustainable Beneficial Effects. Mol Ther Methods Clin Dev 2020;18:335-44. [PMID: 32671136 DOI: 10.1016/j.omtm.2020.06.006] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
17 Han M, Deng C. BDNF as a pharmacogenetic target for antipsychotic treatment of schizophrenia. Neurosci Lett 2020;726:133870. [PMID: 30312750 DOI: 10.1016/j.neulet.2018.10.015] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
18 Skonieczna-Żydecka K, Łoniewski I, Stachowska E, Marlicz W, Correll CU. Current and Novel Approaches to Mitigate Cardiometabolic Adverse Effects of Second-Generation Antipsychotics. Int J Neuropsychopharmacol 2020;23:491-5. [PMID: 32239144 DOI: 10.1093/ijnp/pyaa026] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
19 Burghardt KJ, Howlett BH, Sanders E, Dass SE, Msallaty Z, Mallisho A, Seyoum B, Yi Z. Skeletal muscle DNA methylation modifications and psychopharmacologic treatment in bipolar disorder. Eur Neuropsychopharmacol 2019;29:1365-73. [PMID: 31635791 DOI: 10.1016/j.euroneuro.2019.10.001] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
20 Cheng KC, Li Y, Chang WT, Kuo FY, Chen ZC, Cheng JT. Telmisartan is effective to ameliorate metabolic syndrome in rat model - a preclinical report. Diabetes Metab Syndr Obes 2018;11:901-11. [PMID: 30584345 DOI: 10.2147/DMSO.S187092] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
21 Babic I, Sellers D, Else PL, Nealon J, Osborne AL, Pai N, Weston-Green K. Effect of liraglutide on neural and peripheral markers of metabolic function during antipsychotic treatment in rats. J Psychopharmacol 2021;35:284-302. [PMID: 33570012 DOI: 10.1177/0269881120981377] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
22 Zhou Y, Xu Z, Yu Y, Cao J, Qiao Y, Qiao H, Suo G. Comprehensive analysis of the lncRNA-associated ceRNA network identifies neuroinflammation biomarkers for Alzheimer's disease. Mol Omics 2019;15:459-69. [DOI: 10.1039/c9mo00129h] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.7] [Reference Citation Analysis]
23 Johansen IT, Steen NE, Haram M, Rødevand L, Werner MCF, Lunding SH, Hjell G, Agartz I, Melle I, Lagerberg TV, Nerhus M, Andreassen OA. Sex differences in antipsychotic-related triglyceride levels are associated with metabolic hormone differences in patients with severe mental disorders. Schizophr Res 2022;243:55-63. [PMID: 35240428 DOI: 10.1016/j.schres.2022.02.015] [Reference Citation Analysis]
24 Huo L, Zhang G, Du X, Jia Q, Qian Z, Chen D, Xiu M, Wu F, Soares JC, Huang X, Cassidy RM, Ning Y, Zhang XY. The prevalence, risk factors and clinical correlates of diabetes mellitus in Chinese patients with schizophrenia. Schizophrenia Research 2020;218:262-6. [DOI: 10.1016/j.schres.2019.12.029] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
25 Hanyu S, Kojima Y, Murai T, Kawashima H. Lurasidone-induced hyperosmolar hyperglycemic syndrome: A case report. Neuropsychopharmacol Rep 2022. [PMID: 35609885 DOI: 10.1002/npr2.12259] [Reference Citation Analysis]
26 George MY, Menze ET, Esmat A, Tadros MG, El-Demerdash E. Naringin treatment improved main clozapine-induced adverse effects in rats; emphasis on weight gain, metabolic abnormalities, and agranulocytosis. Drug Dev Res 2021. [PMID: 33537987 DOI: 10.1002/ddr.21800] [Reference Citation Analysis]
27 Lee TH, Cheng KK, Hoo RL, Siu PM, Yau SY. The Novel Perspectives of Adipokines on Brain Health. Int J Mol Sci. 2019;20:5638. [PMID: 31718027 DOI: 10.3390/ijms20225638] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 8.0] [Reference Citation Analysis]
28 Duarte T, Barbisan F, da Cunha BSN, Azzolin VF, Turra BO, Duarte MMMF, da Cruz Jung IE, Ribeiro EE, do Prado-lima PA, da Cruz IBM. The Influence of a Xanthine-Catechin Chemical Matrix on in vitro Macrophage-Activation Triggered by Antipsychotic Ziprasidone. Inflammation 2019;42:915-25. [DOI: 10.1007/s10753-018-0946-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
29 Kucera J, Horska K, Hruska P, Kuruczova D, Micale V, Ruda-Kucerova J, Bienertova-Vasku J. Interacting effects of the MAM model of schizophrenia and antipsychotic treatment: Untargeted proteomics approach in adipose tissue. Prog Neuropsychopharmacol Biol Psychiatry 2021;108:110165. [PMID: 33152383 DOI: 10.1016/j.pnpbp.2020.110165] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
30 Abo Alrob O, Alazzam S, Alzoubi K, Nusair MB, Amawi H, Karasneh R, Rababa'h A, Nammas M. The Effect of Long-Term Second-Generation Antipsychotics Use on the Metabolic Syndrome Parameters in Jordanian Population. Medicina (Kaunas) 2019;55:E320. [PMID: 31261805 DOI: 10.3390/medicina55070320] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
31 Turkheimer FE, Selvaggi P, Mehta MA, Veronese M, Zelaya F, Dazzan P, Vernon AC. Normalizing the Abnormal: Do Antipsychotic Drugs Push the Cortex Into an Unsustainable Metabolic Envelope? Schizophr Bull 2020;46:484-95. [PMID: 31755955 DOI: 10.1093/schbul/sbz119] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
32 Ellfolk M, Leinonen MK, Gissler M, Lahesmaa-korpinen A, Saastamoinen L, Nurminen M, Malm H. Second-generation antipsychotics and pregnancy complications. Eur J Clin Pharmacol 2020;76:107-15. [DOI: 10.1007/s00228-019-02769-z] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
33 Lian J, Deng C. The dosage-dependent effects of cevimeline in preventing olanzapine-induced metabolic side-effects in female rats. Pharmacol Biochem Behav 2020;191:172878. [PMID: 32112786 DOI: 10.1016/j.pbb.2020.172878] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
34 Chen J, Vitetta L. Mitochondria could be a potential key mediator linking the intestinal microbiota to depression. J Cell Biochem 2020;121:17-24. [PMID: 31385365 DOI: 10.1002/jcb.29311] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
35 Cernea S, Dima L, Correll CU, Manu P. Pharmacological Management of Glucose Dysregulation in Patients Treated with Second-Generation Antipsychotics. Drugs 2020;80:1763-81. [PMID: 32930957 DOI: 10.1007/s40265-020-01393-x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
36 Tosur M, Viau-Colindres J, Astudillo M, Redondo MJ, Lyons SK. Medication-induced hyperglycemia: pediatric perspective. BMJ Open Diabetes Res Care 2020;8:e000801. [PMID: 31958298 DOI: 10.1136/bmjdrc-2019-000801] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
37 Xu M, Guo S, Yang F, Wang Y, Wu C, Jiang X, Zhao Q, Chen W, Tian G, Zhu F, Xie Y, Hu T, Wang Z, He Y, Shen J. Continuation of structure–activity relationship study of novel benzamide derivatives as potential antipsychotics. Arch Pharm Chem Life Sci 2019;352:1800306. [DOI: 10.1002/ardp.201800306] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
38 Fève B, Scheen AJ. When therapeutic drugs lead to diabetes. Diabetologia 2022. [PMID: 35244742 DOI: 10.1007/s00125-022-05666-w] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
39 He M, Huang X, Gao G, Zhou T, Li W, Hu J, Chen J, Li J, Sun T. Olanzapine-induced endoplasmic reticulum stress and inflammation in the hypothalamus were inhibited by an ER stress inhibitor 4-phenylbutyrate. Psychoneuroendocrinology 2019;104:286-99. [DOI: 10.1016/j.psyneuen.2019.03.017] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
40 Kosmalski M, Różycka-kosmalska M, Sikora J, Pietras T. Diabetes mellitus in patients using psychotropic medications: How does it work? Postepy Hig Med Dosw 2021;75:398-405. [DOI: 10.5604/01.3001.0014.9330] [Reference Citation Analysis]